BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4156503)

  • 1. Plasma renin response to acute blockade of angiotensin II in the anaesthetized rat.
    Oates HF; Stokes GS; Glover RG
    Clin Exp Pharmacol Physiol; 1974; 1(2):155-60. PubMed ID: 4156503
    [No Abstract]   [Full Text] [Related]  

  • 2. Time course of changes in plasma renin after blockade of the renin-system. Studies of conscious and anaesthetized, normal, adrenalectomized and spontaneously hypertensive rats.
    Bing J; Poulsen K
    Acta Pathol Microbiol Scand A; 1975 Sep; 83(5):454-66. PubMed ID: 170788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of renin-angiotensin system in experimental hypertension in rats: plasma renin and hypotensive effect of angiotensin II antagonist.
    Yamamoto J
    Jpn Circ J; 1977 Jun; 41(6):665-75. PubMed ID: 886656
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of angiotensin II blockade by saralasin (1-Sar-8-Ala-angiotensin II) in normal man.
    Ibsen H; Kappelgaard AM; Nielsen MD; Giese J
    Eur J Clin Pharmacol; 1978 Nov; 14(3):171-6. PubMed ID: 729612
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of angiotensin II blockade in conscious sodium-depleted dogs.
    Stephens GA; Davis JO; Freeman RH; Watkins BE; Khosla MC
    Endocrinology; 1977 Aug; 101(2):378-8. PubMed ID: 885110
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
    Ibsen H; Leth A; McNair A; Giese J
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():123s-125s. PubMed ID: 396064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
    Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic changes after angiotensin II blockade by saralasin (author's transl)].
    Liebau G; Beyer J; Larbig D; Schick K; Sekanina G; Hayduk K
    Klin Wochenschr; 1977 Jul; 55(13):647-9. PubMed ID: 19645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin blockade in studies of the feedback control of renin release in rats and rabbits.
    Stokes GS; Oates HF; Weber MA
    Clin Sci Mol Med Suppl; 1975 Jun; 2():33s-36s. PubMed ID: 1077786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ; Boyd GW; Peart WS
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal and tubuloglomerular feedback effects of [Sar1,Ala8]angiotensin II in the rat.
    Ploth DW; Roy RN
    Am J Physiol; 1982 Feb; 242(2):F149-57. PubMed ID: 7039342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
    Schroeder ET; Anderson GH; Goldman SH; Streeten DH
    Kidney Int; 1976 Jun; 9(6):511-9. PubMed ID: 940284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Action of 1-sar-8-ala-angiotensin II (saralasin) on the feedback mechanism between renin and angiotensin II].
    Ochs HG; Brass H; Lamberts G; Heintz R
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():193-4. PubMed ID: 613566
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of sar-ala8 angiotensin II (saralasin) responsiveness in hypertension of renal origin.
    Arendell R; Lawson JD; Petracek MR; Meacham PW; Hollifield JW; Dean RH
    J Surg Res; 1978 Apr; 24(4):284-7. PubMed ID: 642496
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin II blockade in patients with essential hypertension.
    MacGregor GA; Dawes PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):53-4. PubMed ID: 1071404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of biological effects of three angiotensin II antagonists in sodium depleted hypertensive patients.
    Ogihara T; Nakamaru M; Higaki J; Hata T; Kumagai A; Kumahara Y
    Med J Osaka Univ; 1983 Sep; 34(1-2):21-5. PubMed ID: 6366501
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative studies of the humoral and arterial pressure responses to Sar1-Ala8-, Sar1-Ile8 and Sar1-Thr8-angiotensin II in the trained unanaesthetized dog.
    Bravo EL; Khosla MC; Bumpus FM
    Prog Biochem Pharmacol; 1976; 12():33-40. PubMed ID: 1019168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of renovascular hypertension with angiotensin II blockade.
    Baer L; Parra-Carrilo JZ; Radichevich I; Williams GS
    Ann Intern Med; 1977 Mar; 86(3):257-60. PubMed ID: 842983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.